전체메뉴
Article Search

VSI Vascular Specialist International

Open Access

pISSN 2288-7970
eISSN 2288-7989
QR Code QR Code

Review

Related articles in VSI

More Related Articles

Article

Review

Vasc Specialist Int (2023) 39:23

Published online September 4, 2023 https://doi.org/10.5758/vsi.230056

Copyright © The Korean Society for Vascular Surgery.

Technical Tips for Performing Suprahepatic Vena Cava Tumor Thrombectomy in Renal Cell Carcinoma without Using Cardiopulmonary Bypass

Jun Gyo Gwon1 , Yong-Pil Cho1 , Youngjin Han1 , Jungyo Suh2 , and Seung-Kee Min3

1Division of Vascular Surgery, Department of Surgery, 2Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 3Division of Vascular Surgery, Department of Surgery, Seoul National University Hospital, Seoul, Korea

Correspondence to:Seung-Kee Min
Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
Tel: 82-2-2072-0297
Fax: 82-2-766-3975
E-mail: skminmd@snuh.org
https://orcid.org/0000-0002-1433-2562

Received: June 21, 2023; Revised: July 27, 2023; Accepted: August 2, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Radical nephrectomy with tumor thrombectomy for advanced renal cell carcinoma is an oncologically relevant approach that can achieve long-term survival even in the presence of distant metastases. However, the surgical techniques pose significant challenges. The objective of this clinical review was to present technical recommendations for tumor thrombectomy in the vena cava to facilitate surgical treatment. Transesophageal echocardiography is required to prepare for this procedure. Cardiopulmonary bypass should be considered when the tumor thrombus has invaded the cardiac chamber and clamping is not feasible because of the inability to milk the intracardiac chamber thrombus in the caudal direction. Prior to performing a cavotomy, it is crucial to clamp the contralateral renal vein and infrarenal and suprahepatic inferior vena cava (IVC). If the suprahepatic IVC is separated from the surrounding tissue, it can be gently pulled down toward the patient’s leg until the lower margin of the atrium becomes visible. Subsequently, the tumor thrombus should be carefully pulled downward to a position where it can be clamped. Implementing the Pringle maneuver to reduce blood flow from the hepatic veins to the IVC during IVC cavotomy is simpler than clamping the hepatic veins. Sequential clamping is a two-stage method of dividing thrombectomy by clamping the IVC twice, first suprahepatically and then midretrohepatically. This sequential clamping technique helps minimize hypotension status and the Pringle maneuver time compared to single clamping. Additionally, a spiral cavotomy can decrease the degree of primary closure narrowing. The oncological prognoses of patients can be improved by incorporating these technical recommendations.

Keywords: Renal cell carcinoma, Tumor thrombectomy, Inferior vena cava

INTRODUCTION

Renal cell carcinoma (RCC) remains one of the most life-threatening malignancies in urology, despite advances in treatment methods following changes in the medical environment [1]. A distinguishing feature of RCC is that the tumor thrombus extends through the vein into the bloodstream [2]. In approximately 4%-15% of individuals with RCC, tumor cells invade the renal vein or inferior vena cava (IVC), resulting in a tumor thrombus [3-9]. RCC with venous tumor thrombosis (VTT) in the vena cava is categorized into several stages according to the thrombus level (Fig. 1) [10].

Figure 1. Tumor thrombus level based on the Mayo classification.

At level III, the thrombus reaches the IVC above the hepatic vein, but not above the atrium, and at level IV, the thrombus extends above the diaphragmatic IVC or right atrium. For level III and IV tumor thrombi, removal from the vena cava is very challenging because of the need for high-level vena cava clamping and extensive tissue dissection [11,12]. However, combining radical nephrectomy with tumor thrombectomy is an oncologically relevant approach that can achieve long-term survival, even in the presence of distant metastases [13]. This clinical review aimed to introduce tips for surgical techniques concerning tumor thrombectomy in the vena cava to aid the surgical treatment of RCC with VTT.

PREOPERATIVE PREPARATION

1) Minimal invasive surgery

In recent years, the use of minimally invasive surgery for RCC with VTT has increased, with some studies showing favorable results [14,15]. However, robotic or laparoscopic surgery is limited to level I and II tumor thrombosis. Therefore, there is insufficient evidence to predict the outcomes and safety of minimally invasive surgery when applied to level III and IV tumor thrombosis.

2) Anticoagulation and preoperative renal artery embolization

Although a recent study showed the potential benefit of preventing venous thromboembolism, there is little evidence to support the use of anticoagulants in patients with RCC with VTT before surgery [16]. Renal artery embolization before surgery may facilitate surgery by inducing renal angioinfarction to reduce kidney volume and bleeding; however, there are concerns about its safety. Some studies have suggested that this procedure can reduce surgical duration and blood loss [17-20], but it can also cause various immunological problems when tissue infarction occurs. Postinfarction syndrome may lead to fever, chills, flank pain, hematuria, hypertension, and hyponatremia, which can delay surgery and be harmful to patients with RCC [21-23]. One study showed no significant differences in perioperative mortality and 5-year cancer-related survival between the groups with and without prior renal artery embolization [24]. Therefore, preoperative renal artery embolization is not recommended due to the lack of evidence supporting its benefits and potential risks it may pose.

3) Transesophageal echocardiography and cardiopulmonary bypass

In cases of level III and IV VTT, the upper margin of the thrombus must be identified to enable clamping from the upper side of the thrombus. Therefore, simultaneous monitoring of the tumor thrombus is required, particularly to detect the occurrence of embolism. Additionally, cardiac function monitoring is necessary when the IVC is clamped because the cardiac preload will be rapidly reduced, and cardiac function may deteriorate severely [25,26]. Therefore, transesophageal echocardiography (TEE) should be available for intraoperative use. A cardiopulmonary bypass (CPB) may be necessary in some cases. CPB should be considered when the tumor thrombus penetrates the cardiac chamber and clamping is impossible due to the inability to milk the intracardiac chamber thrombus caudally. Hypothermia, in which the body temperature is lowered to ≤30ºC, may be used to reduce ischemic sequelae when CPB is performed. However, hypothermia can cause coagulopathy and bleeding, which can increase the perioperative mortality rate [27-32].

SURGICAL APPROACH

1) Renal vessel management

When exposure to the surgical field is achieved, ligation of the renal artery is the first step. Inducing infarction by blocking the renal artery preoperatively causes postinfarction syndrome, which is not beneficial for the patient. However, ligation of the renal artery during surgery reduces blood flow and decreases the amount of perioperative bleeding around the kidney [33]. It is convenient to perform renal artery ligation and division in advance during the dissection of tissue. This is because it is difficult to manipulate the renal artery during IVC dissection and thrombectomy. In right-sided RCC, ligation of the renal artery is easier to perform between the aorta and the IVC than around the renal hilum. This procedure reduces the manipulation required to isolate the renal artery from the renal hilum tissue. In the renal vein, if the thrombus is floating and not attached to the IVC wall, caution is required, as the thrombus may cause embolism toward the cephalic direction when the origin stalk is divided while the vein is ligated and resected.

2) Dissection of the retrohepatic IVC and central diaphragm tendon

Before performing a cavotomy, preparation for clamping the contralateral renal vein and infrarenal and suprahepatic IVC is necessary. In the case of infrarenal IVC, the flow is restricted due to the proximal thrombus, and the collateral veins, including the lumbar veins, often become relatively larger than normal [34]. Therefore, ligation of these veins must be performed prior to cavotomy. In retrohepatic IVC, short hepatic veins can be torn during vena caval thrombectomy or blood can be introduced into the cavotomy site; therefore, all identified veins should be ligated and divided. A piggybacked liver mobilization must be completed to ensure circumferential IVC control and facilitate subsequent sequential clamping [35,36].

Even if a thrombus is located above the diaphragm, a method to perform thrombectomy without performing sternotomy or CPB has also been introduced [37-39]. For this procedure, it is necessary to first completely isolate the IVC from the central tendon of the diaphragm. If the IVC is separated from the surrounding tissue, it can be pulled down toward the patient’s leg until the lower margin of the atrium is visible (Fig. 2). A pericardiotomy can be performed to widen the exposed area of the atrium, if necessary. Care should be taken as the coronary sinus may be invaded if the clamp is raised excessively [40]. When the supradiaphragmatic IVC is completely exposed, the tumor thrombus must be carefully pulled downward to a position where it can be clamped [41]. This milking-down process should be performed carefully while touching the thrombus with the thumb and forefinger and monitored with intraoperative TEE to ensure that the free-floating thrombus does not cause embolization (Fig. 3). At this time, if a round-shaped DeBakey or Satinsky vascular clamp is used for the supradiaphragmatic IVC, a higher level of clamping is possible than a linear-shaped vascular clamp, while reducing the risk of fragmentation of the thrombus tip.

Figure 2. Exposure of the supradiaphragmatic inferior vena cava within the thoracic cage through dissection of the central tendon and inferior vena cava.

Figure 3. Gentle traction of the tumor thrombus in the inferior vena cava using a finger, while being cautious to prevent embolism.

3) The Pringle maneuver

The hepatic veins exhibit many variations at the point where the middle, right, and left hepatic veins join the IVC [42]. In many cases, the liver parenchyma must be dissected to clamp the hepatic veins separately at the level just before their junction with the IVC. Therefore, performing the Pringle maneuver to reduce blood flow from the hepatic veins to the IVC during cavotomy is easier than clamping the hepatic veins [43,44]. After clamping the hepatic pedicle for the Pringle maneuver, the surface of the liver is gently squeezed to remove any remaining blood inside the liver. If IVC clamping is performed after squeezing the liver, blood loss inside the liver flowing out during cavotomy can be reduced, and the volume of the liver also decreases; thus, a good view can be secured during thrombectomy [45]. If the Pringle maneuver is performed for more than 20 minutes, reperfusion is required for 5 minutes [46]. However, if sequential clamping is performed, vena cava thrombectomy at the level of the hepatic vein can be completed within 20 minutes, even with meticulous inspection and removal of the thrombus from the IVC intima.

4) Sequential clamping

Sequential clamping is a method of dividing the thrombectomy into two stages by clamping the IVC twice: first suprahepatically and then midretrohepatically (Fig. 4). This method offers several advantages over one-time clamping. First, it can reduce the time during which blood pressure is lowered. In infrahepatic IVC clamping, blood flow through the hepatic vein is maintained to some extent, and the degree of blood pressure drop is less than that during suprahepatic IVC clamping, which blocks the flow of the hepatic vein. Minimizing the time spent on the first upper-level thrombectomy and quickly restoring hepatic vein flow by changing from a suprahepatic IVC clamp to a retrohepatic IVC clamp reduces the duration of low blood pressure. CPB should be performed if complications are expected because of a significant decrease in blood pressure during test clamping performed prior to cavotomy [47]. However, since there is no consensus on the acceptable blood pressure reduction during test clamping, it is important to minimize the time spent on blood pressure reduction that occurs during IVC clamping as much as possible. It also has the advantage of reducing the duration of blocking hepatic flow in the Pringle maneuver. The Pringle maneuver, which is performed to block hepatic flow, causes ischemic damage to the liver in a time-dependent manner. However, to investigate closely whether a remnant tumor is attached to the IVC intima, the time required for the Pringle maneuver must be increased. If a hepatic vein-level IVC thrombectomy is completed in the first clamping among the sequential clamps, the Pringle maneuver can be terminated. Subsequently, the second sequential clamping for vena caval thrombectomy can be performed on the remaining thrombus. The actual sequence of the procedure is as follows: first, the suprahepatic IVC is clamped, followed by the midretrohepatic IVC. Subsequently, vena caval thrombectomy is performed as quickly as possible in the clamped area, and the IVC is closed. Next, because a part of the tumor may have been trapped below the lower clamp site, the clamp is repositioned slightly higher than the previous retrohepatic IVC clamp, and the suprahepatic IVC clamp and Pringle maneuver are released to restore the flow of the hepatic vein. Finally, the infrarenal IVC and opposite renal vein are clamped, and thrombectomy is performed for any remaining thrombus.

Figure 4. Sequential clamping of the inferior vena cava to minimize hemodynamic instability time.

5) Spiral cavotomy and closure

When performing a cavotomy, it is best to perform it spirally, especially near the renal vein, and include the renal vein in the spiral cavotomy. This allows a thorough examination of any residual tumor thrombus that may remain at the ostium of the renal vein. If the narrowing is >50% during the closure of cavotomy site with a running suture, a patch angioplasty should be performed to prevent complications due to IVC narrowing [48,49]. However, if a spiral cavotomy is performed, the degree of primary closure narrowing can be reduced. Although spiral cavotomy makes it difficult to simultaneously perform a wide-range thrombectomy, sequential clamping can be performed to examine the interior of the IVC in detail. When closing the cavotomy site after thrombectomy, a running suture could be performed using 4-0 prolene. While releasing the clamp, it is advisable to adopt the Trendelenburg position immediately before releasing it to minimize the risk of air embolism because air can enter the IVC [50]. If tumor invasion occurs in the IVC, the risk of local recurrence is high [51]. In such cases, the IVC wall must be resected and reconstructed; however, recent studies have shown that IVC interruption does not increase the risk of postoperative complications [52]. If the IVC is interrupted, postoperative anticoagulants should be administered [53].

OUTCOMES AFTER TUMOR THROMBECTOMY WITH RADICAL NEPHRECTOMY

There are a few studies on surgery for level III or IV tumor thrombi without CPB, but the rates of perioperative complications and mortality are not high compared with those of CPB [43,54]. Complications include an embolism of tumor thrombus during IVC manipulation or clamping and massive blood loss. Since an individual surgeon’s experience is very important in reducing complications and mortality, it is generally recommended to perform surgery at high-volume centers because complication rates tend to increase with the level of thrombus [51,53]. In terms of oncological outcomes, at 5 years, cancer-specific survival for patients following radical nephrectomy and tumor thrombectomy ranges between 30% and 70% [4,55-57].

CONCLUSION

Performing vena cava thrombectomy for level III and IV RCC with VTT is challenging. However, this can be accomplished without intraoperative complications if appropriate thrombectomy techniques are used. High-level thrombectomy can also be performed without CPB by milking down the thrombus through the central diaphragmatic tendon dissection. Sequential IVC clamping and the Pringle maneuver can reduce the low blood pressure time and minimize the blood loss, allowing for a more detailed thrombectomy. Spiral cavotomy can help maintain smoothen venous flow. The oncological prognoses of patients can be improved using the aforementioned technical tips.

FUNDING

None.

CONFLICTS OF INTEREST

Jun Gyo Gwon, Youngjin Han, and Seung-Kee Min have been the editorial board members of the VSI since 2019. They were not involved in the review process. Otherwise, no potential conflict of interest relevant to this article was reported.

AUTHOR CONTRIBUTIONS

Jun Gyo Gwon, Youngjin Han, and Seung-Kee Min have been the editorial board members of the VSI since 2019. They were not involved in the review process. Otherwise, no potential conflict of interest relevant to this article was reported.

Concept and design: SKM. Analysis and interpretation: SKM. Writing the article: JGG, YH, YPC. Critical revision of the article: JS. Final approval of the article: all authors. Statistical analysis: none. Obtained funding: none. Overall responsibility: SKM.

Fig 1.

Figure 1.Tumor thrombus level based on the Mayo classification.
Vascular Specialist International 2023; 39: https://doi.org/10.5758/vsi.230056

Fig 2.

Figure 2.Exposure of the supradiaphragmatic inferior vena cava within the thoracic cage through dissection of the central tendon and inferior vena cava.
Vascular Specialist International 2023; 39: https://doi.org/10.5758/vsi.230056

Fig 3.

Figure 3.Gentle traction of the tumor thrombus in the inferior vena cava using a finger, while being cautious to prevent embolism.
Vascular Specialist International 2023; 39: https://doi.org/10.5758/vsi.230056

Fig 4.

Figure 4.Sequential clamping of the inferior vena cava to minimize hemodynamic instability time.
Vascular Specialist International 2023; 39: https://doi.org/10.5758/vsi.230056

References

  1. Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, et al. Epidemiology of renal cell carcinoma. Eur Urol 2019;75:74-84. https://doi.org/10.1016/j.eururo.2018.08.036
    Pubmed KoreaMed CrossRef
  2. Noguchi K, Hori D, Nomura Y, Tanaka H. Renal cell carcinoma with tumor-thrombus extension into the right ventricle. Ann Vasc Dis 2012;5:376-380. https://doi.org/10.3400/avd.cr.11.00067
    Pubmed KoreaMed CrossRef
  3. Nouh MA, Inui M, Kakehi Y. Renal cell carcinoma with IVC thrombi; current concepts and future perspectives. Clin Med Oncol 2008;2:247-256. https://doi.org/10.4137/cmo.s464
    Pubmed KoreaMed CrossRef
  4. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004;94:33-41. https://doi.org/10.1111/j.1464-410x.2004.04897.x
    Pubmed CrossRef
  5. Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?. J Urol 2004;171(2 Pt 1):588-591. https://doi.org/10.1097/01.ju.0000104672.37029.4b
    Pubmed CrossRef
  6. Parekh DJ, Cookson MS, Chapman W, Harrell F Jr, Wells N, Chang SS, et al. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. J Urol 2005;173:1897-1902. https://doi.org/10.1097/01.ju.0000158459.42658.95
    Pubmed CrossRef
  7. Lambert EH, Pierorazio PM, Shabsigh A, Olsson CA, Benson MC, McKiernan JM. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology 2007;69:1054-1058. https://doi.org/10.1016/j.urology.2007.02.052
    Pubmed CrossRef
  8. Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, et al. Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 2007;178(4 Pt 1):1189-1195; discussion 1195. https://doi.org/10.1016/j.juro.2007.05.134
    Pubmed CrossRef
  9. Kim H, Han Y, Ko GY, Jeong MJ, Choi K, Cho YP, et al. Clinical outcomes of a preoperative inferior vena cava filter in acute venous thromboembolism patients undergoing abdominal-pelvic cancer or orthopedic surgery. Vasc Specialist Int 2018;34:103-108. https://doi.org/10.5758/vsi.2018.34.4.103
    Pubmed KoreaMed CrossRef
  10. Neves RJ, Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987;59:390-395. https://doi.org/10.1111/j.1464-410x.1987.tb04832.x
    Pubmed CrossRef
  11. Reese AC, Whitson JM, Meng MV. Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol 2013;31:1305-1309. https://doi.org/10.1016/j.urolonc.2011.12.006
    Pubmed CrossRef
  12. Lee JS, Moon T, Kim TH, Kim SY, Choi JY, Lee KB, et al. Deep vein thrombosis in patients with pulmonary embolism: prevalance, clinical significance and outcome. Vasc Specialist Int 2016;32:166-174. https://doi.org/10.5758/vsi.2016.32.4.166
    Pubmed KoreaMed CrossRef
  13. Kaag MG, Toyen C, Russo P, Cronin A, Thompson RH, Schiff J, et al. Radical nephrectomy with vena caval thrombectomy: a contemporary experience. BJU Int 2011;107:1386-1393. https://doi.org/10.1111/j.1464-410x.2010.09661.x
    Pubmed KoreaMed CrossRef
  14. Ashrafi AN, Gill IS. Minimally invasive radical nephrectomy: a contemporary review. Transl Androl Urol 2020;9:3112-3122. https://doi.org/10.21037/tau-2019-suc-16
    Pubmed KoreaMed CrossRef
  15. Chopra S, Simone G, Metcalfe C, de Castro Abreu AL, Nabhani J, Ferriero M, et al. Robot-assisted level II-III inferior vena cava tumor thrombectomy: step-by-step technique and 1-year outcomes. Eur Urol 2017;72:267-274. Erratum in: Eur Urol 2021;80:e64. https://doi.org/10.1016/j.eururo.2016.08.066
    Pubmed KoreaMed CrossRef
  16. Kaptein FHJ, van der Hulle T, Braken SJE, van Gennep EJ, Buijs JT, Burgmans MC, et al. Prevalence, treatment, and prognosis of tumor thrombi in renal cell carcinoma. JACC CardioOncol 2022;4:522-531. https://doi.org/10.1016/j.jaccao.2022.07.011
    Pubmed KoreaMed CrossRef
  17. Bakal CW, Cynamon J, Lakritz PS, Sprayregen S. Value of preoperative renal artery embolization in reducing blood transfusion requirements during nephrectomy for renal cell carcinoma. J Vasc Interv Radiol 1993;4:727-731. https://doi.org/10.1016/s1051-0443(93)71958-2
    Pubmed CrossRef
  18. Craven WM, Redmond PL, Kumpe DA, Durham JD, Wettlaufer JN. Planned delayed nephrectomy after ethanol embolization of renal carcinoma. J Urol 1991;146:704-708. https://doi.org/10.1016/s0022-5347(17)37899-0
    Pubmed CrossRef
  19. Klimberg I, Hunter P, Hawkins IF, Drylie DM, Wajsman Z. Preoperative angioinfarction of localized renal cell carcinoma using absolute ethanol. J Urol 1985;133:21-24. https://doi.org/10.1016/s0022-5347(17)48768-4
    Pubmed CrossRef
  20. Wotkowicz C, Wszolek MF, Libertino JA. Resection of renal tumors invading the vena cava. Urol Clin North Am 2008;35:657-671, viii. https://doi.org/10.1016/j.ucl.2008.07.013
    Pubmed CrossRef
  21. Subramanian VS, Stephenson AJ, Goldfarb DA, Fergany AF, Novick AC, Krishnamurthi V. Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi. Urology 2009;74:154-159. https://doi.org/10.1016/j.urology.2008.12.084
    Pubmed CrossRef
  22. Schwartz MJ, Smith EB, Trost DW, Vaughan ED Jr. Renal artery embolization: clinical indications and experience from over 100 cases. BJU Int 2007;99:881-886. https://doi.org/10.1111/j.1464-410x.2006.06653.x
    Pubmed CrossRef
  23. May M, Brookman-Amissah S, Pflanz S, Roigas J, Hoschke B, Kendel F. Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma. Br J Radiol 2009;82:724-731. https://doi.org/10.1259/bjr/17514226
    Pubmed CrossRef
  24. Martínez-Salamanca JI, Linares E, González J, Bertini R, Carballido JA, Chromecki T, et al. Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Curr Urol Rep 2014;15:404. https://doi.org/10.1007/s11934-014-0404-7
    Pubmed CrossRef
  25. González J, Andrés G, Martínez-Salamanca JI, Ciancio G. Improving surgical outcomes in renal cell carcinoma involving the inferior vena cava. Expert Rev Anticancer Ther 2013;13:1373-1387. https://doi.org/10.1586/14737140.2013.858603
    Pubmed CrossRef
  26. Thangaswamy CR, Manikandan R, Bathala Vedagiri SC. Role of transoesophageal echocardiography in renal cell carcinoma: a brief review. BMJ Case Rep 2017;2017:bcr2017221532. https://doi.org/10.1136/bcr-2017-221532
    Pubmed KoreaMed CrossRef
  27. Gocoł R, Hudziak D, Bis J, Mendrala K, Morkisz Ł, Podsiadło P, et al. The role of deep hypothermia in cardiac surgery. Int J Environ Res Public Health 2021;18:7061. https://doi.org/10.3390/ijerph18137061
    Pubmed KoreaMed CrossRef
  28. Condello I, Nasso G, Serraino GF, Mastroroberto P, Fiore F, Speziale G, et al. The evolution of temperature management for cardiac surgery: a historical perspective. J Cardiothorac Vasc Anesth 2022;36(8 Pt B):3237-3243. https://doi.org/10.1053/j.jvca.2021.12.023
    Pubmed CrossRef
  29. Linardi D, Faggian G, Rungatscher A. Temperature management during circulatory arrest in cardiac surgery. Ther Hypothermia Temp Manag 2016;6:9-16. https://doi.org/10.1089/ther.2015.0026
    Pubmed CrossRef
  30. Linassi F, Maran E, De Laurenzis A, Tellaroli P, Kreuzer M, Schneider G, et al. Targeted temperature management in cardiac surgery: a systematic review and meta-analysis on postoperative cognitive outcomes. Br J Anaesth 2022;128:11-25. https://doi.org/10.1016/j.bja.2021.09.042
    Pubmed CrossRef
  31. Nussmeier NA. Management of temperature during and after cardiac surgery. Tex Heart Inst J 2005;32:472-476.
    Pubmed KoreaMed
  32. Saad H, Aladawy M. Temperature management in cardiac surgery. Glob Cardiol Sci Pract 2013;2013:44-62. https://doi.org/10.5339/gcsp.2013.7
    Pubmed KoreaMed CrossRef
  33. Yang Q, Du J, Zhao ZH, Chen XS, Zhou L, Yao X. Fast access and early ligation of the renal pedicle significantly facilitates retroperitoneal laparoscopic radical nephrectomy procedures: modified laparoscopic radical nephrectomy. World J Surg Oncol 2013;11:27. https://doi.org/10.1186/1477-7819-11-27
    Pubmed KoreaMed CrossRef
  34. Li SJ, Lee J, Hall J, Sutherland TR. The inferior vena cava: anatomical variants and acquired pathologies. Insights Imaging 2021;12:123. https://doi.org/10.1186/s13244-021-01066-7
    Pubmed KoreaMed CrossRef
  35. Hevia V, Ciancio G, Gómez V, Álvarez S, Díez-Nicolás V, Burgos FJ. Surgical technique for the treatment of renal cell carcinoma with inferior vena cava tumor thrombus: tips, tricks and oncological results. Springerplus 2016;5:132. https://doi.org/10.1186/s40064-016-1825-1
    Pubmed KoreaMed CrossRef
  36. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989;210:649-652. https://doi.org/10.1097/00000658-198911000-00013
    Pubmed KoreaMed CrossRef
  37. Tabbara MM, González J, Ciancio G. Renal cell carcinoma with supradiaphragmatic tumor thrombus: avoiding sternotomy and cardiopulmonary bypass. Med Res Arch 2022;10:10.18103/mra.v10i7.2913. https://doi.org/10.18103/mra.v10i7.2913
    Pubmed KoreaMed CrossRef
  38. Ciancio G, Farag A, Salerno T. Renal cell carcinoma with inferior vena cava tumor thrombus in two patients with previous coronary artery bypass graft: strategy for surgical removal. Front Surg 2021;8:676245. https://doi.org/10.3389/fsurg.2021.676245
    Pubmed KoreaMed CrossRef
  39. Ciancio G, Shirodkar SP, Soloway MS, Livingstone AS, Barron M, Salerno TA. Renal carcinoma with supradiaphragmatic tumor thrombus: avoiding sternotomy and cardiopulmonary bypass. Ann Thorac Surg 2010;89:505-510. https://doi.org/10.1016/j.athoracsur.2009.11.025
    Pubmed CrossRef
  40. Akay MH, Patel MK, Gregoric ID. Coronary sinus injury resulting from endarterectomy during multivessel bypass surgery. Interact Cardiovasc Thorac Surg 2017;24:804-805. https://doi.org/10.1093/icvts/ivw393
    Pubmed CrossRef
  41. Ciancio G, Livingstone AS, Soloway M. Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. Eur Urol 2007;51:988-994; discussion 994-995. https://doi.org/10.1016/j.eururo.2006.11.055
    Pubmed CrossRef
  42. Sureka B, Sharma N, Khera PS, Garg PK, Yadav T. Hepatic vein variations in 500 patients: surgical and radiological significance. Br J Radiol 2019;92:20190487. https://doi.org/10.1259/bjr.20190487
    Pubmed KoreaMed CrossRef
  43. Dellaportas D, Arkadopoulos N, Tzanoglou I, Bairamidis E, Gemenetzis G, Xanthakos P, et al. Technical intraoperative maneuvers for the management of inferior vena cava thrombus in renal cell carcinoma. Front Surg 2017;4:48. https://doi.org/10.3389/fsurg.2017.00048
    Pubmed KoreaMed CrossRef
  44. Jibiki M, Iwai T, Inoue Y, Sugano N, Kihara K, Hyochi N, et al. Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava. J Vasc Surg 2004;39:829-835. https://doi.org/10.1016/j.jvs.2003.12.004
    Pubmed CrossRef
  45. Chaib E, Saad WA, Fujimura I, Saad WA Jr, Gama-Rodrigues J. The main indications and techniques for vascular exclusion of the liver. Arq Gastroenterol 2003;40:131-136. https://doi.org/10.1590/s0004-28032003000200013
    Pubmed CrossRef
  46. Wei X, Zheng W, Yang Z, Liu H, Tang T, Li X, et al. Effect of the intermittent Pringle maneuver on liver damage after hepatectomy: a retrospective cohort study. World J Surg Oncol 2019;17:142. https://doi.org/10.1186/s12957-019-1680-y
    Pubmed KoreaMed CrossRef
  47. Psutka SP, Leibovich BC. Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma. Ther Adv Urol 2015;7:216-229. https://doi.org/10.1177/1756287215576443
    Pubmed KoreaMed CrossRef
  48. Hyams ES, Pierorazio PM, Shah A, Lum YW, Black J, Allaf ME. Graft reconstruction of inferior vena cava for renal cell carcinoma stage pT3b or greater. Urology 2011;78:838-843. https://doi.org/10.1016/j.urology.2011.06.016
    Pubmed CrossRef
  49. Mansukhani NA, Havelka GE, Helenowski IB, Rodriguez HE, Hoel AW, Eskandari MK. The enduring patency of primary inferior vena cava repair. Surgery 2017;161:1414-1422. https://doi.org/10.1016/j.surg.2016.11.006
    Pubmed KoreaMed CrossRef
  50. McCarthy CJ, Behravesh S, Naidu SG, Oklu R. Air embolism: practical tips for prevention and treatment. J Clin Med 2016;5:93. https://doi.org/10.3390/jcm5110093
    Pubmed KoreaMed CrossRef
  51. Abel EJ, Carrasco A, Karam J, Tamboli P, Delacroix S, Vaporciyan AA, et al. Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus. BJU Int 2014;114:667-673. https://doi.org/10.1111/bju.12515
    Pubmed CrossRef
  52. Liu Z, Zhang Q, Zhao X, Zhu G, Tang S, Hong P, et al. Inferior vena cava interruption in renal cell carcinoma with tumor thrombus: surgical strategy and perioperative results. BMC Surg 2021;21:402. https://doi.org/10.1186/s12893-021-01400-2
    Pubmed KoreaMed CrossRef
  53. Boorjian SA, Sengupta S, Blute ML. Renal cell carcinoma: vena caval involvement. BJU Int 2007;99(5 Pt B):1239-1244. https://doi.org/10.1111/j.1464-410x.2007.06826.x
    Pubmed CrossRef
  54. Simon RM, Kim T, Espiritu P, Kurian T, Sexton WJ, Pow-Sang JM, et al. Effect of utilization of veno-venous bypass vs. cardiopulmonary bypass on complications for high level inferior vena cava tumor thrombectomy and concomitant radical nephrectomy. Int Braz J Urol 2015;41:911-919. https://doi.org/10.1590/s1677-5538.ibju.2014.0371
    Pubmed KoreaMed CrossRef
  55. Pouliot F, Shuch B, Larochelle JC, Pantuck A, Belldegrun AS. Contemporary management of renal tumors with venous tumor thrombus. J Urol 2010;184:833-841; quiz 1235. https://doi.org/10.1016/j.juro.2010.04.071
    Pubmed CrossRef
  56. Hirono M, Kobayashi M, Tsushima T, Obara W, Shinohara N, Ito K, et al. Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan. BMC Cancer 2013;13:447. https://doi.org/10.1186/1471-2407-13-447
    Pubmed KoreaMed CrossRef
  57. Haddad AQ, Wood CG, Abel EJ, Krabbe LM, Darwish OM, Thompson RH, et al. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort. J Urol 2014;192:1050-1056. https://doi.org/10.1016/j.juro.2014.03.111
    Pubmed CrossRef